Organovo Highlights FXR314 Combination Therapy Potential and Plan
SAN DIEGO, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO), a clinical stage biotechnology company that is...
Read more
K36 Therapeutics Named “Overall BioPharma Startup of the Year” By BioTech Breakthrough
Annual Awards Program Recognizes Innovation in the Global Life Sciences and Biotechnology IndustryCAMBRIDGE, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) --...
Read moreGaruda Therapeutics Named “Overall Cell Biology Company of the Year” By BioTech Breakthrough
Annual Awards Program Recognizes Innovation in the Global Life Sciences and Biotechnology IndustryLOS ANGELES, Nov. 08, 2023 (GLOBE NEWSWIRE) --...
Read moreHistoSonics Edison System Recognized With BioTech Breakthrough Award For “MedTech Innovation Of The Year”
Annual Awards Program Recognizes Innovation in the Global Life Sciences and Biotechnology IndustryLOS ANGELES, Nov. 08, 2023 (GLOBE NEWSWIRE) --...
Read moreSIO Logistics Growing 900% with Tai Software
- Tai’s TMS and automation propel SIO Logistics to unprecedented growth - HUNTINGTON BEACH, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE)...
Read moreNuvectis Pharma, Inc. Reports Third Quarter 2023 Financial Results and Business Highlights
Phase 1b Study of NXP800 in Patients with Platinum Resistant, ARID1a-Mutated Ovarian Carcinoma is Ongoing Initiated the Phase 1a Dose...
Read moreVericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
Record Third Quarter Revenue of $45.6 Million, Representing 18% Growth versus Prior Year MACI Revenue Growth of 21% to $37.6...
Read moreVictoria’s Secret & Co. to Maximize Supplier Diversity Efforts through Unique Programs
Through its partnerships with minority-owned cotton farms, its supplier diversity events and collaboration with the Fifteen Percent Pledge, VS&Co amplifies...
Read moreThe Habit Burger Grill Celebrates Drive-Thru In Easley, Its Third Restaurant In South Carolina
The Habit Burger Grill To Open Its Doors To The Public On November 15, and Hold Pre-Opening VIP Events On...
Read moreInvestigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting
Showed HCW9218 clinical safety and tumor response endpointsfor 15 patients with heavily pretreated advanced solid tumors Results in ovarian cancer...
Read moreADVERTISEMENTS
Shortcodes Ultimate
ADVERTISEMENTS
